Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Rang in aandelen #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Aandeelprijs
$11.03
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$597.15M
Verandering (1 dag)
-4.25%
Verandering (1 jaar)
-
Land
US
Handel Eikon Therapeutics, Inc. Common Stock (EIKN)

Categorie

Aandelsplitsingen voor Eikon Therapeutics, Inc. Common Stock (EIKN)
Het aandeel Eikon Therapeutics, Inc. Common Stock (symbool: EIKN) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 31, 2026.
Eén aandeel EIKN dat vóór Aug 31, 2026 werd gekocht, staat nu gelijk aan 0 aandelen EIKN.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH